Last reviewed · How we verify

NCT02264834

Deambulatory Epidural During the Labour

Completed Phase 3 Last updated 31 May 2018
What this trial tests

Phase 3 trial testing Levobupivacaine 0.1% + Sufentanil 0.2µg/ml in First Pregnancy in 164 participants. Completed in 20 March 2018.

Timeline
1 July 2014
Primary endpoint
20 March 2018
20 March 2018

Quick facts

Lead sponsorDr Madeleine Wilwerth
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment164
Start date1 July 2014
Primary completion20 March 2018
Estimated completion20 March 2018
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Dr Madeleine Wilwerth — full company profile →

Who can join

Adults 18 to 40, female only, with First Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assess the impact of instrumentation and caesarean related to dyskinesia by reducing the concentration of local anesthetic and therefore the motor block.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for First Pregnancy

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02264834.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing